Syfovre
Payments companies reported to CMS as associated with Syfovre. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Syfovre, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Syfovre
These are the largest totals companies reported as associated with Syfovre. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dilsher Dhoot | Santa Barbara, CA | Retina Specialist | $248,096.46 |
| Ehsan Rahimy | Stanford, CA | Retina Specialist | $230,961.73 |
| Ankur Shah | Carmel, IN | Retina Specialist | $216,256.52 |
| Jonathan Jonisch | Great Neck, NY | Ophthalmology | $190,533.57 |
| Rishi Singh | Boston, MA | Ophthalmology | $180,495.84 |
| Nathan Steinle | Santa Barbara, CA | Retina Specialist | $153,475.95 |
| Roger Goldberg | Walnut Creek, CA | Retina Specialist | $151,954.69 |
| Joseph Coney | Beachwood, OH | Retina Specialist | $142,341.19 |
| Deepak Sambhara | Wausau, WI | Ophthalmology | $125,886.87 |
| David Eichenbaum | St Petersburg, FL | Ophthalmology | $112,930.82 |
Prescribed Syfovre?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.